Diversified Trust CO Tg Therapeutics, Inc. Transaction History

Diversified Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$15.2 - $35.51 $330,919 - $773,088	-21,771 Closed	0 $0
Q3 2021 Jan 13, 2022	BUY	$21.78 - $40.45 $21,780 - $40,450	1,000 Added 4.81%	21,771 $725,000
Q2 2021 Jul 20, 2021	BUY	$32.5 - $48.96 $32 - $48	1 Added 0.0%	20,771 $806,000
Q1 2021 May 10, 2021	BUY	$41.61 - $54.3 $400,953 - $523,234	9,636 Added 86.55%	20,770 $1 Million
Q4 2020 Jan 08, 2021	BUY	$25.27 - $54.9 $281,356 - $611,256	11,134 New	11,134 $579,000

375

85.5M

3.78M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $5.58B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.